Knowledge, attitudes, perceptions, and misconceptions among vitiligo patients in Southwest, Saudi Arabia
DOI:
https://doi.org/10.66344/jpad.v34i4(Suppl).3049Keywords:
Vitiligo, Herbal compounds, Misconceptions, PerceptionsAbstract
Objective The study assesses the degree of knowledge possessed by patients with vitiligo in southwest Saudi Arabia regarding the disease’s etiology, diagnosis, management, and prognosis. Additionally, the study identifies factors associated with patients’ knowledge about the disease.
Methods The study administered a questionnaire in Arabic and English languages to measure the patients' knowledge about the causes of vitiligo, associated conditions, and available treatment options. The questionnaire was distributed among 293 patients diagnosed with vitiligo in the dermatology outpatient clinics at Khamis Mushayt General Hospital and King Khalid Hospital in Najran during the study period. Data analysis was conducted using χ2 test for categorical variables.
Results 293 patients were recruited in this study. Of these, 124 (42.3%) were male, and 169 (57.7%) were female. Most patients were young, falling within the age group of 22–39 years. Approximately 156 (53.3%) of the patients possessed no awareness regarding causes of vitiligo. Only 52 (17.7%) patients demonstrated good knowledge related to vitiligo, while 241 (82.3%) had poor knowledge. Stress and fear were considered causative or aggravating factors by 68 (23.2%) patients. Additionally, only 138 (47.1%) patients were aware that the loss of pigment cells contributes to vitiligo. Herbal compounds were considered effective treatment agents by 56 (19.1%) patients. In addition, 211 (72%) patients were aware of vitiligo treatment with topical steroids, but 82 (28%) responded that they did not know about these treatment modalities.
Conclusion Erroneous beliefs, misconceptions, and myths surrounding vitiligo were uncovered in this study. These misconceptions often lead to delayed medical advice-seeking and poor adherence to medication. To address this, health education programs should be implemented by health authorities, focusing on mass disease education.
References
1. Alfahaad, Hamad. Clinico-epidemiological profile of vitiligo patients in Najran Region, Saudi Arabia. J Dermatol Dermatol Surg. 2015;19:31-5.
2. Joge RR, Kathane PU, Joshi SH. Vitiligo: A Narrative Review. Cureus. 2022:14(9): 29307.
3. Perez-Bootello J, Cova-Martin R, Naharro-Rodriguez J, Segurado-Miravalles G. Vitiligo: Pathogenesis and New and Emerging Treatments. Int J Mol Sci. 2023;24(24):17306. https://doi.org/10.3390/ijms242417306
4. Alghamdi KM, Moussa NA, Mandil A, et al. Public Perceptions and Attitudes Toward Vitiligo. J Cut Med Surg. 2012;16(5):334-40.
5. Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol. 2005;152(6):1165-72.
6. Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. (2003);58:1.
7. Nasser, M.A., Raggi El Tahlawi, S.M., Abdelfatah, Z.A. et al. Stress, anxiety, and depression in patients with vitiligo. Middle East Curr Psychiatry. 2021:28:63.
8. Baldini E, Odorisio T, Sorrenti S, Catania A, Tartaglia F, Carbotta G, Pironi D, Rendina R, D'Armiento E, Persechino S, Ulisse S. Vitiligo and Autoimmune Thyroid Disorders. Front Endocrinol (Lausanne). 2017;8:290.
9. Boniface K, Seneschal J, Picardo M, Taïeb A. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy. Clin Rev Allergy Immunol. 2018;54(1):52-67.
10. Al-Mubarak L, Al-Mohanna H, Al-Issa A, Jabak M, Mulekar SV. Quality of life in saudi vitiligo patients. J Cut Aesthet Surg. 2021;4(1):33–7. https://doi.org/10.4103/0974-2077.79188
11. Rork JF, Rashighi M, Harris JE. Understanding autoimmunity of vitiligo and alopecia areata. Curr Opin Pediatr. 2016;28(4):463-9.
12. Silpa-Archa N, Pruksaeakanan C, Angkoolpakdeekul N, Chaiyabutr C, Kulthanan K, Ratta-Apha W, Wongpraparut C. Relationship Between Depression and Quality of Life Among Vitiligo Patients: A Self-assessment Questionnaire-based Study. Clin Cosmet Investig Dermatol. 2020;13:511-520. https://doi.org/10.2147/CCID.S265349
13. Alzeer FA, Alajlan A, Alshammari SA, Ahamed SS, Alzeer AH. Depression and Quality of Life among Saudi Patients with Vitiligo: A Descriptive Quantitative Review.
Open Dermatol J. 2023.
https://doi.org/10.2174/18743722-v17-e230907-2023-5
14. Bin Saif GA, Al-Balbeesi AO, Binshabaib R, Alsaad D, Kwatra SG, Alzolibani AA, Yosipovitch G. Quality of life in family members of vitiligo patients: a questionnaire study in Saudi Arabia. Am J Clin Dermatol. 2013;14(6):489-95.
15. Ferrari SM, Fallahi P, Santaguida G, Virili C, Ruffilli I, Ragusa F, Centanni M, Antonelli A. Circulating CXCL10 is increased in non-segmental vitiligo, in presence or absence of autoimmune thyroiditis. Autoimmun Rev. 2017;16(9):946-50.
16. Antonelli A, Benvenga S. Editorial: The Association of Other Autoimmune Diseases in Patients With Thyroid Autoimmunity. Front Endocrinol (Lausanne). 2018;9:540.
17. Keraryi FA, Hakami AAH, Hakami NA, Mahfouz MS, Hakami HAH. Does the Saudi Population Have Sufficient Awareness of Vitiligo in Southwest Saudi Arabia? A Cross-Sectional Survey, 2022. Clin Pract, 2022;12(6):876–84. https://doi.org/10.3390/clinpract12060092
18. Almohideb, M.. (2020). Epidemiological Patterns of Skin Disease in Saudi Arabia: A Systematic Review and Meta-Analysis. Dermatology Research and Practice. 2020, Article ID 5281957,
https://doi.org/10.1155/2020/5281957
19. Fatani, M. I., Aldhahri, R. M., Al Otaibi, H. O., Kalo, B. B., & Khalifa, M. A.. (2016). Acknowledging popular misconceptions about vitiligo in western Saudi Arabia. J Dermatol Surg. 2016;20(1):27–31.
https://doi.org/https://doi.org/10.1016/j.jdds.2015.09.001
20. Al-Shammari SA, Alotaibi HM, Assiri MA, Altokhais MI, Alotaibi MS, Alkhowailed MS. Quality of life in vitiligo patients in central Saudi Arabia. Saudi Med J. 2021;42(6):682-7. https://doi.org/10.15537/smj.2021.42.6.20200833
21. Jarallah JS, Al-Sheikh OA, El-Shabrawy M, Al-Wakeel MA. Vitiligo: Epidemiology and clinical pattern at King Khalid University Hospital. Ann Saudi Med. 1993;13(4):332-4.
https://doi.org/10.5144/0256-4947.1993.332
22. Molla A, Alayoubi AM, Jannadi R. First Cousin Marriages and the Risk of Childhood-Onset Vitiligo: Exploring the Genetic Background: A Cross-Sectional Study. Clin Cosmet Investig Dermatol. 2024;17:1471-9.
https://doi.org/10.2147/CCID.S470937
23. Al Robaee AA. Assessment of quality of life in Saudi patients with vitiligo in a medical school in Qassim province, Saudi Arabia. Saudi Med J. 2007;28(9):1414-7.
24. Spritz RA, Andersen GH. Genetics of Vitiligo. Dermatol Clin. 2017;35(2):245-55. doi: 10.1016/j.det.2016.11.013.
PMID: 28317533; PMCID: PMC5362127.
25. Alissa A, Al Eisa A, Huma R, Mulekar S. Vitiligo-epidemiological study of 4134 patients at the National Center for Vitiligo and Psoriasis in Central Saudi Arabia. Saudi Med J. 2011;32(12):1291-6.
PMID: 22159386.
26. AL-smadi, K.; Imran, M.; Leite-Silva, V.R.; Mohammed, Y. Vitiligo: A Review of Aetiology, Pathogenesis, Treatment, and Psychosocial Impact. Cosmetics 2023;10: 84.
https://doi.org/10.3390/cosmetics10030084
27. Sarma N, Chakraborty S, Poojary S, Shashi Kumar BM, Gupta LK, Budamakuntla L, et al. A Nationwide, Multicentric Case-Control Study on Vitiligo (MEDEC-V) to Elicit the Magnitude and Correlates. Indian J Dermatol. 2020;65(6):473-82. doi: 10.4103/ijd.IJD_822_19. PMID: 33487702; PMCID: PMC7810087.
28. Nordlund, JJ. Vitiligo and Other Hypomelanosis of Hair and Skin. Arch Dermatol. 1985;121(7):935-6.
https://doi.org/10.1001/ARCHDERM.1985.01660070125036
29. Zhang Y, Cai Y, Shi M, Jiang S, Cui S, Wu Y, Gao XH, Chen HD. The Prevalence of Vitiligo: A Meta-Analysis. PLoS One. 2016;11(9):e0163806.
doi: 10.1371/journal.pone.0163806. PMID: 27673680; PMCID: PMC5038943.
30. Al-Mutairi N, Sharma AK, Al-Sheltawy M, Nour-Eldin O. Childhood vitiligo: a prospective hospital-based study. Aust J Dermatol. 2005;46(3):150-3.
https://doi.org/10.1111/J.1440-0960.2005.00167.X
31. Alenizi DA. Consanguinity pattern and heritability of Vitiligo in Arar, Saudi Arabia. J Fam Comm Med. 2014;21(1): 13–6.
https://doi.org/10.4103/2230-8229.128767
32. Borimnejad L, Parsa Yekta Z, Nikbakht-Nasrabadi A, Firooz A. Quality of life with vitiligo: comparison of male and female muslim patients in Iran. Gend Med. 2006;3(2):124-30. doi: 10.1016/s1550-8579(06)80201-9. PMID: 16860271.
33. Samela T, Malorni W, Matarrese P, Mattia G, Alfani S, Abeni D. Gender differences in vitiligo: psychological symptoms and quality of life assessment description. Front Psychol. 2023;14:1234734.
34. Sampogna F, Raskovic D, Guerra L, Pedicelli C, Tabolli S, Leoni L, Alessandroni L, Abeni D. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol. 2008;159(2):351-9. doi: 10.1111/j.1365-2133.2008.08678.x. Epub 2008 Jun 28. PMID: 18565189.
35. Vedamurthy M, Kumar M, Boda S. Exploring the spectrum of vitiligo: Clinical and demographic perspectives – A cross-sectional study. Cosmo Derma. 2024;4:40.doi: 10.25259/CSDM_168_2023
36. Mahfouz MS, Alqassim AY, Hakami FA, Alhazmi AK, Ashiri AM, Hakami AM, Khormi LM, Adawi YM, Jabrah AA (2023). Common Skin Diseases and Their Psychosocial Impact among Jazan Population, Saudi Arabia: A Cross-Sectional Survey during 2023. Medicina. 2023;59(10):1753. https://doi.org/10.3390/medicina59101753
37. Sharaf F. Prevailing misconceptions of vitiligo among Saudi School children. Int J Health Sci. 2014;8:33-8.
doi: 10.12816/0006069.
38. Mahajan VK, Vashist S, Chauhan PS, Mehta KIS, Sharma V, Sharma A. Clinico-Epidemiological Profile of Patients with Vitiligo: A Retrospective Study from a Tertiary Care Center of North India. Indian Dermatol Online J. 2019;10(1):38-44.
doi: 10.4103/idoj.IDOJ_124_18. PMID: 30775297; PMCID: PMC6362747.
39. Ecker UKH, Lewandowsky S, Cook J. The psychological drivers of misinformation belief and its resistance to correction. Nat Rev Psychol. 2022;1:13-29
https://doi.org/10.1038/s44159-021-00006-y
40. Murshidi R, Shewaikani N, Al Refaei A, Alfreijat B, Al-Sabri B, Abdallat M, Murshidi M, Khamis T, Al-Dawoud Y, Alattar Z. Public Knowledge and Attitude towards Vitiligo: A Cross-Sectional Survey in Jordan. Int J Environ Res Public Health. 2023;20(12):6183.
doi: 10.3390/ijerph20126183. PMID: 37372769; PMCID: PMC10298545.
41. Alsunni AA, Albaker WI, Badar A. Determinants of misconceptions about diabetes among Saudi diabetic patients attending diabetes clinic at a tertiary care hospital in Eastern Saudi Arabia. J Family Community Med. 2014;21(2):93-9.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Hamad Alfahaad, Saleh Mesfer Alghamdi, Soliman Alsaiari, Wadha Alfarwan, Anwar Ali Farhan, Mahdi Alfataih, Mohammed Al Ameer, Enas Al Hadi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
